$400M Pfizer Class Action Settlement On Track For Approval
A proposed $400 million deal to resolve a class action lawsuit accusing Pfizer Inc. of misleading investors about illegal off-label drug marketing was put on track for approval on Thursday, but...To view the full article, register now.
Already a subscriber? Click here to view full article